N
Nicholas Bellamy
Researcher at University of Queensland
Publications - 229
Citations - 29320
Nicholas Bellamy is an academic researcher from University of Queensland. The author has contributed to research in topics: WOMAC & Clinical trial. The author has an hindex of 62, co-authored 229 publications receiving 27128 citations. Previous affiliations of Nicholas Bellamy include St. Vincent's Health System & Royal Brisbane and Women's Hospital.
Papers
More filters
Journal Article
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
TL;DR: WOMAC is a disease-specific purpose built high performance instrument for evaluative research in osteoarthritis clinical trials and fulfil conventional criteria for face, content and construct validity, reliability, responsiveness and relative efficiency.
Journal ArticleDOI
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
Dennis C. Turk,Robert H. Dworkin,Robert R. Allen,Nicholas Bellamy,Nancy A. Brandenburg,Daniel B. Carr,Charles S. Cleeland,Raymond A. Dionne,John T. Farrar,Bradley S. Galer,David J. Hewitt,Alejandro R. Jadad,Nathaniel P. Katz,Lynn D. Kramer,Donald C. Manning,Cynthia McCormick,Michael P. McDermott,Patrick J. McGrath,Steve Quessy,Bob A. Rappaport,James P. Robinson,Mike A. Royal,Lee S. Simon,Joseph W. Stauffer,Wendy M. Stein,Jane Tollett,James Witter +26 more
TL;DR: In this article, the authors provide recommendations for the core outcome domains that should be considered by investigators conducting clinical trials of the efficacy and effectiveness of treatments for chronic pain, and develop a core set of outcome domains would facilitate comparison and pooling of d
Journal ArticleDOI
Topical Review and RecommendationsCore outcome measures for chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin,Dennis C. Turk,John T. Farrar,Jennifer A. Haythornthwaite,Mark P. Jensen,Nathaniel P. Katz,Robert D. Kerns,Gerold Stucki,Robert R. Allen,Nicholas Bellamy,Daniel B. Carr,Julie Chandler,Penney Cowan,Raymond A. Dionne,Bradley S. Galer,Sharon Hertz,Alejandro R. Jadad,Lynn D. Kramer,James Witter +18 more
Journal ArticleDOI
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
Florence Tubach,Philippe Ravaud,Gabriel Baron,Bruno Falissard,Isabelle Logeart,Nicholas Bellamy,Claire Bombardier,David T. Felson,Marc C. Hochberg,D. van der Heijde,Maxime Dougados +10 more
TL;DR: Using criteria such as MCII in clinical trials would provide meaningful information which would help in interpreting the results by expressing them as a proportion of improved patients.
Journal ArticleDOI
Viscosupplementation for the treatment of osteoarthritis of the knee
TL;DR: The pooled analyses of the effects of viscosupplementation against 'placebo' controls generally supported the efficacy of this class of intervention and readers should be cautious, therefore, in drawing conclusions regarding the relative value of different products.